A Mechanism for Inhaled Anesthetic-Induced Solid Organ Injury: Inflammation
International Journal of Anesthesia and Clinical Medicine
Volume 2, Issue 1, January 2014, Pages: 1-7
Received: Nov. 28, 2013; Published: Dec. 20, 2013
Views 2160      Downloads 141
Authors
Gary E Hill, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, TX, USA
Irina Gasanova, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, TX, USA
Geoffrey M Thiele, Veterans Administration Alcohol Research Center, Omaha Veterans Administration Medical Center, Woolworth Avenue, Omaha, NE
Article Tools
PDF
Follow on us
Abstract
Background: Inhaled anesthetics, including halothane, iso- and sevoflurane induce proinflammatory cytokine release. Halothane is an inhaled anesthetic agent that is metabolized by the liver into a highly reactive product, trifluoroacetyl chloride, which can react endogenously to form a trifluoroacetyl-adduct (TFA-adduct). The MAA-adduct is formed by acetaldehyde and malondialdehyde reacting with endogenous proteins and is found in both patients and animals post-consumption of alcohol. These TFA and MAA-adducts have been shown to cause the release of proinflammatory cytokines by endogenous inflammatory cells. If both adducts share a similar mechanism of cell activation, receiving general anesthesia following alcohol ingestion could exacerbate the inflammatory response caused by the inhaled general anesthetic halothane and lead to solid organ (including liver and brain) injury. Methods: Control diet and alcohol-fed rats were randomized to receive halothane pretreatments by intraperitoneal injection mixed in sesame oil. Following the intraperitoneal injections, the intact heart was removed, HECs were isolated and stimulated with unmodified bovine serum albumin (Alb), MAA-modified Alb (MAA-Alb), Hexyl-MAA, or lipopolysaccharide (LPS), and supernatant concentrations of TNF-α were determined. Results: Halothane pre-treated rat HECs demonstrated significantly greater TNF-α concentration following MAA-adduct and LPS stimulation than the non-halothane pre-treated in both pair and alcohol-fed rats, but was significantly greater in the alcohol-fed groups. Conclusion: These results demonstrate that halothane and MAA-adduct pre-treatment will increase the inflammatory response (TNF-α release) in rat HECs following LPS and MAA stimulation in vitro. Also, these results suggest that halothane exposure may increase the risk of alcohol-induced solid organ injury secondary to TNF-induced inflammation. Other investigators have reported similar proinflammatory cytokine release with other (isoflurane and sevoflurane) inhaled anesthetic exposure, suggesting inhaled anesthetics should be used with caution in alcohol consuming humans.
Keywords
Inflammation, Tumor Necrosis Factor, Inhaled Anesthetics, Halothane, Solid Organ Injury, Alcohol
To cite this article
Gary E Hill, Irina Gasanova, Geoffrey M Thiele, A Mechanism for Inhaled Anesthetic-Induced Solid Organ Injury: Inflammation, International Journal of Anesthesia and Clinical Medicine. Vol. 2, No. 1, 2014, pp. 1-7. doi: 10.11648/j.ja.20140201.11
References
[1]
L.F.Oropeza-Hernandez ,B. Quintanilla-Vega, R.A. Reyes-Mejia, C.J. Serrano, E.A.Garcia-Latorre, W. Dekant, M.Manno, A. Albores, "Trifluoroacetylated adducts in spermatozoa, testes,liver and plasma and CYP2EI induction in rats after subchronic inhalatory exposure to halothane, "Toxicol Lett, Vol. 144,2003,pp. 105-116.
[2]
A. Boutayeb, S. Boutayeb, "The burden of non communicable diseases in developing countries, "lnt J Equity Health, Vol. 4,2005, pp. 2.
[3]
J.R. Trudell, C.M. Ardies, W.R. Anderson, "The effect of alcohol and anesthetic metabolites on cell membranes. A possible direct immune mechanism," Ann N Y Acad Sci, Vol. 625,1991, pp. 806-817.
[4]
D.J.Tuma, T. Hoffman, M.F. Sorrell, "The chemistry of acetaldehyde­protein adducts," Alcohol AlcoholSuppl,Vol.1, 1991, pp. 271-276.
[5]
D. .Xu, G.M. Thiele, J.L. Beckenhauer, L.W.Klassen, M.F.Sorrell, D.J.Tuma, "Detection of circulating antibodies to malondialdehyde­acetaldehyde adducts in ethanol-fed rats", Gastroenterology, Vol.115,1998, pp. 686-692.
[6]
R. Rolla, D. Vay, E. Mottaran, M. Parodi, N. Traverso, S. Arico, M. Sartori, G. Bellomo, L.W. Klassen, G.M. Thiele,D.J.Tuma, E. Albano E, "Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease", Hepatology, Vol.31,2000, pp.878-884.
[7]
D.A. Slatter, M. Murray, A.J. Bailey, "Formation of a dihydropyridine derivative as a potential cross-link derived from malondialdehyde in physiological systems", FEBS Lett, Vol. 421,1998,pp.180-184.
[8]
U. Christen, M. Burgin, J. Gut J, "Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides",Mol Pharmacol,Vol. 40,1991, pp. 390-400.
[9]
G.E.Hill, J.A. Miller, B.T.Baxter, L.W. Klassen, M.J. Duryee, D.J.Tuma, G.M. Thiele "Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury", Atherosclerosis, Vol.141,1998, pp.107-116.
[10]
N.R. Pumford, B.M. Martin, D. Thomassen, J.A. Burris, J.G. Kenna, J.L. Martin, L.R. Pohl LR, "Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72", Chern Res Toxicol, Vol 6,1993, pp.609-615.
[11]
J. Huwyler, J. Gut, "Exposure to the chlorofluorocarbon substitute 2,2-dichloro-1,1,1- trifluoroethane and the anesthetic agent halothane is associated with transient protein adduct formation in the heart", Biochem Biophys Res Commun, Vol.184,1992,pp. 1344-1349.
[12]
D.K.Spracklin, D.C. Hankins, J.M. Fisher, K.E. Thummel, E.D. Kharasch, "Cytochrome P450 2EI is the principal catalyst of human oxidative halothane metabolism in vitro", J Pharmacol Exp Ther, Vol. 281,1997, pp. 400-411.
[13]
A. Meskar, E. Plee-Gautier, Y. Amet, F. Berthou, D. Lucas D,"Alcohol­xenobiotic interactions. Role of cytochrome P450 2EI",.PatholBiol (Paris), Vol. 49,2001, pp. 696-702.
[14]
K.Kikugawa, H. Kosugi, T. Asakura, "Effect of malondialdehyde, a product of lipid peroxidation, on the function and stability of hemoglobin", Arch Biochem BiophysVol. 229, 1984, pp.7-14.
[15]
D.J. Tuma, G.M. Thiele, D. Xu D, L.W. Klassen, M.F. Sorrell MF, "Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration", Hepatology, Vol.23,1996, pp.872-880.
[16]
M.M. Bradford, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding", AnalBiochemVol.72, 1976,pp. 248-254.
[17]
C.S. Lieber, L.M. DeCarli "The feeding of ethanol in liquid diets", Alcohol Clin Exp Res, Vol.10,1986, pp.550-553.
[18]
B. Ferry, J. Halttunen, D.Leszczynski, H. Schellekens, P.H. Meide, P. Hayry, "Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells", Transplantation Vol. 44, 1987, pp.499-503.
[19]
C. Korzeniewski, D.M.Callewaert, " An enzyme-release assay for natural cytotoxicity", J lmmunol MethodsVol.64, 1983, pp.313-320.
[20]
O. Niemela, S. Parkkila, S. Yla-Herttuala, J. Villanueva, B. Ruebner, C.H. Halsted ,"Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease", Hepatology, Vol.22, 1995, pp.1208-1214.
[21]
P.G. Jorens, F.J. Van Overveld, H. Bult, P.A. Vermeire, A.G.Herman, "L­arginine-dependent production of nitrogen oxides by rat pulmonary macrophages", Eur J Pharmacol, Vol. 200, 1991, pp.205-209.
[22]
J.S. Pober, "TNF as an activator of vascular endothelium", Ann Inst Pasteur lmmunol, Vol. 139, 1988, pp. 317-323.
[23]
R.Ferrari, T. Bachetti, L. Agnoletti, L. Comini, S. CurelloS, "Endothelial function and dysfunction in heart failure", Eur Heart J, Vol 19 Suppl G,1998, pp. G41-47.
[24]
E.S. Bour, L.K. Ward,G.A. Cornman, H.C. lsom, "Tumor necrosis factor-alpha-induced apoptosis in hepatocytes in long-term culture", Am J Pathol, Vol.148, 1996, pp.485-495.
[25]
L. Rossig, J. Hoffmann, B. Hugel, Z.Mallat, A. Haase, J.M. Freyssinet, A. Tedgui A. A. Aicher, A.M. Zeiher, S. Dimmeler, "Vitamin C inhibits endothelial cell apoptosis in congestive heart failure", Circulation, Vol. 104, 2001, pp. 2182-2187.
[26]
B. Chandrasekar, K. Vemula, R.M. Surabhi, M. Li-Weber, L.B. Owen-Schaub, L.E. Jensen, S. Mummidi, "Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death", J BiolChem, Vol.279,2004,pp. 20221-20233.
[27]
E. Ohki, S. Kato, Y. Horie, T. Mizukami, H. Tarnai, H. Yokoyama, E. Ito, M. Fukuda, H. Suzuki, I. Kurose, H. Ishii H, "Chronic ethanol consumption enhances endotoxin induced hepatic sinusoidal leukocyte adhesion", Alcohol Clin Exp Res, Vol.20,1996, pp.350A-355A.
[28]
M.Takaishi, I. Kurose, H. Higuchi, N. Watanabe, T. Nakamura, A. Zeki, J. Nishida, S. Kato, S. Miura, Y. Mizuno, P.R. Kvietys, D.N.Granger, H. Ishii, "Ethanol-induced leukocyte adherence and albumin leakage in rat mesenteric venules: role of CD18/intercellular adhesion molecule-1", Alcohol Clin Exp Res, Vol.20,1996, pp. 347A-349A.
[29]
I. Durak, O. Kurtipek,H.S. Ozturk, M. Birey, T. Guven, M. Kavutcu, M. Kacmaz, B. Dikmen, M. Yel, O. Canbolat, "Impaired antioxidant defence in guinea pig heart tissues treated with halothane", Can J Anaesth, Vol. 44,1997,pp. 1014-1020.
[30]
A.A. Harcombe, L. Ramsay, J.G. Kenna, J. Koskinas, H.J. Why, P.J .Richardson, P. L. Weissberg, G.J. Alexander, "Circulating antibodies to cardiac protein-acetaldehyde adducts in alcoholic heart muscle disease", Clin Sci (Lond), Vol.88,1995,pp. 263-268.
[31]
E.Z. Hanna, S.P. Chou, B.F. Grant, "The relationship between drinking and heart disease morbidity in the United States: results from the National Health Interview Survey", Alcohol ClinExp Res, Vol.21, 1997, pp. 111-118.
[32]
G. Torre-Amione, S. Kapadia, J. Lee, J.B. Durand, R.D. Bies,J.B. Young, D.L. Mann, "Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart", Circulation, Vol. 93,1996,pp. 704-711.
[33]
U. Christen, M. Burgin, J. Gut,"Halothane metabolism: Kupffer cells carry and partially process trifluoroacetylated protein adducts", Biochem Biophys Res Commun, Vol.175,1991,pp. 256-262.
[34]
S.J. Smart, T.B. Casale, "TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent", Am J Physiol Vol.266, 1994,pp. L238-45.
[35]
X. Wu, Y. Lu, Y. Dong, G. Zhang, Y. Zhang, X. Zhipeng, D. Culley, G.Crosby, E. Marcontonio, R. Tanzi, Z. Xie,"The inhalation anesthetic isoflurane increased levels of proinflammatory TNF-α, IL-6, and IL-18",Neurobiol Aging, Vol. 33, 2012,pp. 1364-1378.
[36]
D. Lin, Z. Zuo, "Isoflurane induces hippocampal cell injury and cognitive impairments in adult rats", Neuropharmacol, Vol. 61, 2011, pp. 1354-1359.
[37]
L. Zhang, J.Zhang, L. Yang, Y. Dong, Y. Zhang, Z. Xie, "Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells", Brit J Anaesth, Vol. 110(suppl 1), 2013, pp. i82-i91.
[38]
Z. Xie, Y. Dong, U. Maeda, R. Moir, S. Inouye, D. Culley, G. Crosby, R. Tanzi, "Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia", J Gerontol, Vol. 61A, 2006, pp. 1300-1306.
[39]
E. Lin, S. Calvano, Lowry S, "Inflammatory cytokines and cell response in surgery", Surgery, Vol. 127, 2000, pp. 117-126.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186